Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Krystal Biotech Q2 EPS $(0.74) Down From $(0.37) YoY

Krystal Biotech (NASDAQ:KRYS) reported quarterly losses of $(0.74) per share. This is a 100 percent decrease over losses of $(0.37) per share from the same period last year.

byBenzinga Newsdesk

August 9, 2021

1 minute read

Krystal Biotech (NASDAQ:KRYS) reported quarterly losses of $(0.74) per share. This is a 100 percent decrease over losses of $(0.37) per share from the same period last year.

Goldman Sachs Maintains Neutral on Virgin Galactic Hldgs, Lowers Price Target to $6

By Benzinga Newsdesk

Today, 8:19 AM

Goldman Sachs analyst Noah Poponak maintains Virgin Galactic Hldgs (NYSE:SPCE) with a Neutral and lowers the price target from $12 to $6.

SPCE

Heliogen Q2 EPS $(0.11) Misses $(0.06) Estimate

By Benzinga Newsdesk

Today, 8:19 AM

Heliogen (NYSE:HLGN) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.06) by 83.33 percent.

HLGN

Piper Sandler Upgrades Alnylam Pharmaceuticals to Overweight, Raises Price Target to $208

By Benzinga Newsdesk

Today, 8:19 AM

Piper Sandler analyst Edward Tenthoff upgrades Alnylam Pharmaceuticals (NASDAQ:ALNY) from Neutral to Overweight and raises the price target from $181 to $208.

ALNY

Why Is Bitcoin Shooting Up Today?

By Shivdeep Dhaliwal

Today, 8:19 AM

Bitcoin (CRYPTO: BTC) traded 4.96% higher at $49,677.72 over 24 hours in the early hours of Thursday. What’s Moving? The apex cryptocurrency was up 3.96% over a seven-day trailing period at press time.

TWTR

Krystal Biotech Q2 EPS $(0.74) Down From $(0.37) YoY

Related Posts

Goldman Sachs Maintains Neutral on Virgin Galactic Hldgs, Lowers Price Target to $6

Heliogen Q2 EPS $(0.11) Misses $(0.06) Estimate

Piper Sandler Upgrades Alnylam Pharmaceuticals to Overweight, Raises Price Target to $208

Why Is Bitcoin Shooting Up Today?